Major adverse cardiovascular events and cause-specific mortality after hospitalisation in COPD
Author(s)
Ioannides, Anne E
Whittaker, Hannah R
Quint, Jennifer K
Type
Journal Article
Abstract
Purpose: People with chronic obstructive pulmonary disease (COPD) are at elevated risk of cardiovascular events and mortality. We aimed to determine, in a COPD population, the relationship between hospitalization and post-discharge one-year rates of (i) major adverse cardiovascular events (MACE) and (ii) cause-specific mortality.
Patients and Methods: We conducted a prospective cohort study on a COPD population, between 01/01/2010 and 31/12/2019, using nationally-representative, routinely collected electronic healthcare records in England (Clinical Practice Research Datalink Aurum primary care data, linked with secondary care [Hospital Episode Statistics], and mortality [Office of National Statistics] data). The exposure was ≥one hospitalization, and the control group was no hospitalization. Outcomes were one-year rates of (i) non-fatal MACE (acute coronary syndrome, arrhythmia, heart failure, or ischemic stroke) and (ii) cause-specific mortality. Exposures were stratified by hospitalization type (elective and emergency) and cause (all-cause, cardiovascular, respiratory, and non-cardiorespiratory). We implemented adjusted Cox proportional hazard regression models, and sensitivity doubly robust propensity score-adjusted models.
Results: Hospitalized COPD patients had significantly higher rates (incidence rate [IR, per 1000 person-years]; adjusted hazard ratio {aHR} [95% confidence interval {95% CI}] of MACE in the year following hospitalization, whether elective (IR=33.3; 7.04 [6.19– 8.07]) or emergency (IR=70.0; 8.85 [7.78– 10.06]), versus those without hospitalization (IR=3.4). Emergency hospitalization was associated with increased all-cause mortality (IR=146.5; 2.49 [2.37– 2.61]), regardless of hospitalization cause, compared to those not hospitalized (IR=30.3). Elective hospitalization was also associated with increased all-cause mortality (IR=54.6; 1.32 [1.25– 1.38]), except for cardiovascular elective hospitalization (1.00 [0.89– 1.12]). Cause-specific mortality was influenced largely by hospitalization cause.
Conclusion: Hospitalized COPD patients experienced increased subsequent one-year MACE and mortality rates, regardless of hospitalization cause or type. Hospitalization for any reason in COPD patients provides an opportunity to provide primary prevention for MACE.
Patients and Methods: We conducted a prospective cohort study on a COPD population, between 01/01/2010 and 31/12/2019, using nationally-representative, routinely collected electronic healthcare records in England (Clinical Practice Research Datalink Aurum primary care data, linked with secondary care [Hospital Episode Statistics], and mortality [Office of National Statistics] data). The exposure was ≥one hospitalization, and the control group was no hospitalization. Outcomes were one-year rates of (i) non-fatal MACE (acute coronary syndrome, arrhythmia, heart failure, or ischemic stroke) and (ii) cause-specific mortality. Exposures were stratified by hospitalization type (elective and emergency) and cause (all-cause, cardiovascular, respiratory, and non-cardiorespiratory). We implemented adjusted Cox proportional hazard regression models, and sensitivity doubly robust propensity score-adjusted models.
Results: Hospitalized COPD patients had significantly higher rates (incidence rate [IR, per 1000 person-years]; adjusted hazard ratio {aHR} [95% confidence interval {95% CI}] of MACE in the year following hospitalization, whether elective (IR=33.3; 7.04 [6.19– 8.07]) or emergency (IR=70.0; 8.85 [7.78– 10.06]), versus those without hospitalization (IR=3.4). Emergency hospitalization was associated with increased all-cause mortality (IR=146.5; 2.49 [2.37– 2.61]), regardless of hospitalization cause, compared to those not hospitalized (IR=30.3). Elective hospitalization was also associated with increased all-cause mortality (IR=54.6; 1.32 [1.25– 1.38]), except for cardiovascular elective hospitalization (1.00 [0.89– 1.12]). Cause-specific mortality was influenced largely by hospitalization cause.
Conclusion: Hospitalized COPD patients experienced increased subsequent one-year MACE and mortality rates, regardless of hospitalization cause or type. Hospitalization for any reason in COPD patients provides an opportunity to provide primary prevention for MACE.
Date Issued
2025-07-19
Date Acceptance
2025-07-08
Citation
International Journal of COPD, 2025, 20, pp.2549-2560
ISSN
1176-9106
Publisher
Dove Medical Press
Start Page
2549
End Page
2560
Journal / Book Title
International Journal of COPD
Volume
20
Copyright Statement
© 2025 Ioannides et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/40703224
PII: 529171
Subjects
cause-specific mortality
COPD
hospitalization
Life Sciences & Biomedicine
MACE
OBSTRUCTIVE PULMONARY-DISEASE
Respiratory System
RISK
Science & Technology
SURVIVAL
Publication Status
Published
Coverage Spatial
New Zealand
Date Publish Online
2025-07-19